"We used our voice to educate on the value of medical innovation and boasted the strength of New Jersey’s vibrant ecosystem, which was responsible for more than 50% of all novel FDA approvals in 2023."
NORTH AMERICA HEAD OF LIFE SCIENCES, CITI COMMERCIAL BANK
"Therapeutic areas that appeal to investors, strong management teams, relationships with large pharma, and the ability to generate data and advance pipelines are key to attracting funding."
PARTNER & AMERICAS INDUSTRY MARKET LEADER, HEALTH SCIENCES AND WELLNESS, EY
"The biotech sector has room to grow. Oncology, blood disorders, immunology, inflammation, rare diseases, and neurology are key therapeutic areas attracting capital and fostering innovation."
“The best way to attract investment is with serious science and well-validated clinical mechanisms of action. An asset in the clinic with a well-described mechanism of action for how it works and peer-reviewed science, including NIH funding, helps with the validity.”
"Pharma.Aero is a unique collaborative platform connecting life sciences shippers and service providers to achieve reliable end-to-end air transport for pharmaceutical cargo."
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.